No Data
No Data
Nuvalent's Promising Clinical Progress and Financial Stability Support Strong Buy Rating
Express News | Nuvalent Inc : Stifel Cuts Target Price to $103 From $105
Nuvalent Q1 Net Loss Widens
Nuvalent (NUVL) reported a Q1 net loss Thursday of $0.69 per diluted share, widening from a loss of $0.44 a year earlier. Analysts surveyed by Capital IQ expected a loss of $0.67 per share. The clinic
Nuvalent | 10-Q: Quarterly report
Express News | Nuvalent Q1 2024 GAAP EPS $(0.69) Misses $(0.68) Estimate
Express News | Nuvalent Inc Q1 Shr View $-0.68, Rev View $0.00 -- Lseg Ibes Data